External Ventricular Drain Market Size, Share & Trends Analysis Report By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage), By Region, And Segment Forecasts, 2020 - 2027

Report Overview

The global external ventricular drain market size was valued at USD 5.3 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2020 to 2027. Rising incidence of neurological disorders and increasing road accidents which results in traumatic brain injuries are major factors driving the market for external ventricular drain. In addition, increasing research activities and rising adoption of technologically advanced products are few other factors contributing towards market growth.

According to the WHO, neurovascular stroke is the second most common cause of death and third most common cause of disability around the world and approximately 60%-80% of all strokes are ischemic. This occurs due to blocked blood vessel which limits the blood supply to the brain or when a weakened blood vessel bursts and bleeds into the surrounding brain. Since, the last four years, the incidence rate of strokes majorly in low- and middle-income countries have increased more than double. For instance, India has a very high incident rate of ischemic stroke and is one of the leading causes of death. According to a recent study by All India Institute of Medical Sciences (AIIMS) 2016, approximately 1.8 million Indians suffer from cerebrovascular stroke every year. Additionally, around 1.1 million people of Europe suffer from ischemic stroke every year. Thus, high incidence of cerebrovascular disorders may lead to intraventricular bleeding (hemorrhage), which in turn demands the use of ventricular drain sets to remove excess cerebrospinal fluid. This is expected to drive the market for external ventricular drain over the forecast period. 

Moreover, increasing incidence of cranial injuries and trauma across the world is a key driver of the market for external ventricular drain. Road accidents, falls and sport injuries are the most common causes of head trauma, and cranial injuries. This results in hospitalization and permanent disability for thousands of individuals every year. Raised intracranial pressure (ICP) after a head injury is considered to have an adverse effect with a mortality rate of around 20%. Thus, continuous monitoring of intracranial pressure is crucial to map the progression of brain injury. As per the WHO, vehicle injuries are projected to be the ninth leading cause of death worldwide. Similarly, according to the Association for Safe International Road Travel 2018 report, about 20-50 million people are injured or disabled every year owing to road accidents. Thus, in the U.S., falls (52%) and road accidents (20%) are the first and second leading causes of all traumatic brain injury related hospitalizations, respectively. This, in turn, will boost the demand for external ventricular drain for the treatment.

Furthermore, rising demand for minimally or noninvasive neurosurgeries to help lower trauma and better patient outcomes is projected to accelerate the growth of the market for external ventricular drain. The growing demand is also due to minimal pain, high cost-efficiency, safety, efficacy, and rapid recovery than in traditional procedures. In addition, minimally invasive neurovascular surgeries involve fewer interruptions of adjacent tissues making the procedure easier and more natural. Additionally, increasing concern for natural appearance and aesthetics as well as less amount of blood loss during surgeries are driving the market for external ventricular drain.

Countries such as the U.S. and Canada have witnessed high prevalence rate of neurovascular disorders and traumatic brain injury. Explosive blasts or gunshots exposure are common cause of brain related injuries in military personnel. For instance, as per the Defense and Veterans Brain Injury Center (DVBIC), around 414,000 TBIs has been reported among the U.S. service members between 2000 and late 2019. On an average, about 1,600 TBIs per month are suffered by U.S. service members. Furthermore, as per the Brain Injury Association Waterloo-Wellington (BIAWW), every year in Canada, over 11,000 people die due to TBIs, and more than 6,000 become permanently disabled post TBIs. Thus, the increasing incidence of neurovascular disorders and brain injuries leads to increase in the number of brain surgeries. This is anticipated to boost the growth of the market for external ventricular drain over the forecast period.

Additionally, the growing awareness regarding neurological illnesses such as hemorrhage, vascular malformations, strokes, and intracranial vascular stenosis are anticipated to create growth opportunities in the market for external ventricular drain. Several initiatives and programs have been launched by governments of various countries to improve public awareness and treatment related to neurological condition such as ischemic stroke. For instance, the Department of Health and Human Services in the U.S. has launched initiative to control the incidence of stroke. This program involves the activities to reduce disorders causing stroke and improve the overall health of the people. Thus, all these initiatives taken globally to raise awareness related to neurovascular disorders and conditions are collectively responsible for driving the market for external ventricular drain.

Application Insights

The traumatic brain injury segment dominated the market for external ventricular drain with the share of 33.7% in 2019. Increasing prevalence of traumatic brain injuries due to road accidents, falls and violence is contributing towards the segment growth. Such injuries lead to hospitalization and permanent disability for thousands of individuals each year. For instance, as per the European Injury Database (IDB), approximately 6.1 million people are treated in hospitals for injuries every year. These injuries include facial and traumatic brain injuries. Similarly, according to the CDC report, an estimated 56,000 seniors are hospitalized every year as a result of head injuries suffered due to falls and 775,000 older adults are living with traumatic brain injury-related disability. This is expected to fuel segment growth during the forecast period.

Furthermore, conditions such as hydrocephalus affect a large number of people across the world. For instance, as per the Hydrocephalus Association, over 1.0 million people are currently suffering from hydrocephalus in the U.S., which is the most common reason for brain surgery. Similarly, over 750,000 people in America are living with normal pressure hydrocephalus (NPH).It is estimated that more than 400,000 babies suffer from infant hydrocephalus each year globally. Such high prevalence of neurovascular disorders along with the rising number of brain surgeries is expected to boost the growth of the market for external ventricular drain during the forecast period.

Regional Insights

North America dominated the external ventricular drain market with a share of 35.6% in 2019. This is owing to the greater incidence of traumatic brain injuries as well as high prevalence of neurovascular disorders. For instance, as per the CDC, stroke is the fifth leading cause of death and more than 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and presence of major medical equipment companies such as, Medtronic, and Integra LifeSciences are also contributing towards the growth of the market for external ventricular drain in the region. Thus, increasing prevalence of neurovascular disorders and brain injuries as well as growing awareness among individuals about associated disorders and treatment are driving the market for external ventricular drain.

In Middle East & Africa (MEA), the market for external ventricular drain is expected to witness the highest CAGR of 8.2% from 2020 to 2027. This is due to the presence of such a huge patient base in the emerging economies, along with rising healthcare expenditures in this region. For instance, according to the International Federation for Spina Bifida and Hydrocephalus, over 375,000 new cases of infant hydrocephalus are reported in sub-Saharan Africa each year. In addition, increasing incidence of road accidents in the MEA countries is rising at an alarming rate and is now the leading cause of mortality among young adults, thereby, expected to propel the growth of the market for external ventricular drain during the forecast period. As per the WHO report, a road-traffic mortality rate of 26.6 deaths per 100,000 people has been registered in this continent.

Key Companies & Market Share Insights

Key companies are adopting various strategies such as strategic collaborations and new product launches to increase their market share and global presence. For instance, in September 2017, Arkis BioSciences received U.S. FDA approval for its “CerebroFlo”- an external ventricular drainage catheter. It is used for insertion into ventricular cavity for external drainage of cerebrospinal fluid.

Companies are engaging into partnerships, acquisitions, and mergers aiming to strengthen their product portfolio, manufacturing capacities, and provide competitive diversity. For instance, in July 2019, Integra LifeSciences has acquired Arkis Biosciences Inc. - developer and provider of neurosurgical devices. This acquisition will bolster the company’s offerings in neurocritical care. Furthermore, in January 2019, Medtronic acquired anIsraeli company- Mazor Robotics in a transaction valued at USD 1.7 billion. Mazor Robotics will become the part of Medtronic’s Neurosurgery business under the Restorative Therapies Group’s Brain Therapies division. This is likely to boost the company’s revenue and global presence in the coming years. Some of the prominent players in the external ventricular drain market include:

• Spiegelberg GmbH & Co. KG

• Medtronic

• Sophysa

• Dispomedica GmbH

• Integra LifeSciences

• Möller Medical GmbH

• B. Braun Melsungen AG

• Fuji Systems

External Ventricular Drain Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global external ventricular drain market report on the basis of application and region:

• Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Traumatic Brain Injury

  • Subarachnoid Hemorrhage

  • Intracerebral Hemorrhage

  • Other Non-traumatic Hydrocephalus Conditions

• Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE